The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2016

Filed:

Sep. 07, 2011
Applicants:

Kyung Sun Kang, Seoul, KR;

Min Soo Seo, Daegu, KR;

Sang Bum Park, Seoul, KR;

Inventors:

Kyung Sun Kang, Seoul, KR;

Min Soo Seo, Daegu, KR;

Sang Bum Park, Seoul, KR;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/07 (2010.01); C12N 5/071 (2010.01); C12N 5/077 (2010.01); A61K 35/50 (2015.01); C12N 5/073 (2010.01); C12N 5/0775 (2010.01); C12N 5/0735 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0655 (2013.01); A61K 35/50 (2013.01); C12N 5/0605 (2013.01); C12N 5/0606 (2013.01); C12N 5/0653 (2013.01); C12N 5/0654 (2013.01); C12N 5/0668 (2013.01);
Abstract

The present invention relates to equine amniotic fluid-derived multipotent stem cells (Eaf-MSCs) and a preparation method thereof. More particularly, the present invention relates to equine amniotic fluid-derived multipotent stem cells which exhibit all negative immunological characteristics with respect to the human markers, CD19, CD20, CD28, CD31, CD34, CD38, CD41A, CD62L, CD62P and CD200, and exhibit all positive immunological characteristics with respect to the human markers, CD44, CD90 and CD105, and have the ability to differentiate into ectoderm, mesoderm or endoderm-derived cells.


Find Patent Forward Citations

Loading…